Anirban Maitra: Raising the tail in Pancreatic Cancer survival
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X, about a recent paper by Daniel Palmer et al. published in Journal of Clinical Oncology:
“Raising the tail in Pancreatic Cancer survival starts with successful R0 resection and completion of adjuvant therapy. About 50 months median survival in R0 patients receiving adjuvant Gemcitabine plus Capecitabine. An alternative for those patients not eligible for mFOLFIRINOX.
Open Access in Journal of Clinical Oncology.”
“Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial”
Authors: Daniel Palmer, Richard Jackson, Christoph Springfeld, Markus Büchler, John Neoptolemos et al.
More posts featuring Anirban Maitra.
Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models.
His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023